Create SD Holdings Co., Ltd. (TYO:3148)
Japan
· Delayed Price · Currency is JPY 3,135.00
+10.00 (0.32%)
May 15, 2025, 3:30 PM JST
Create SD Holdings Revenue
Create SD Holdings had revenue of 114.66B JPY in the quarter ending February 28, 2025, with 8.51% growth. This brings the company's revenue in the last twelve months to 448.68B, up 8.98% year-over-year. In the fiscal year ending May 31, 2024, Create SD Holdings had annual revenue of 422.33B with 10.86% growth.
Revenue (ttm)
448.68B
Revenue Growth
+8.98%
P/S Ratio
0.45
Revenue / Employee
93.53M
Employees
4,797
Market Cap
201.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2024 | 422.33B | 41.37B | 10.86% |
| May 31, 2023 | 380.96B | 30.22B | 8.62% |
| May 31, 2022 | 350.74B | 12.27B | 3.62% |
| May 31, 2021 | 338.48B | 18.89B | 5.91% |
| May 31, 2020 | 319.59B | 33.29B | 11.63% |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
| May 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |